IgE ANTI-PANCREATIC CANCER ANTIBODIES FROM PANCREATIC CANCER PATIENTS MEDIATE ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) AGAINST PANCREATIC CANCER CELLS